Published in Curr Drug Targets on April 01, 2007
Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis (2013) 5.00
Genomic responses in mouse models greatly mimic human inflammatory diseases. Proc Natl Acad Sci U S A (2014) 3.36
Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med (2008) 2.93
IL-15 prevents apoptosis, reverses innate and adaptive immune dysfunction, and improves survival in sepsis. J Immunol (2009) 1.91
Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors. Intensive Care Med (2008) 1.11
Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance? Int J Mol Sci (2009) 1.08
Splenectomy protects against sepsis lethality and reduces serum HMGB1 levels. J Immunol (2008) 1.05
Glycogen synthase kinase-3 negatively regulates anti-inflammatory interleukin-10 for lipopolysaccharide-induced iNOS/NO biosynthesis and RANTES production in microglial cells. Immunology (2008) 1.03
IL-10 administration reduces PGE-2 levels and promotes CR3-mediated clearance of Escherichia coli K1 by phagocytes in meningitis. J Exp Med (2010) 1.02
Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspective. Crit Care (2012) 1.00
Analysis of common germline polymorphisms as prognostic factors in patients with lymph node-positive breast cancer. J Cancer Res Clin Oncol (2010) 0.90
IL-10 helps control pathogen load during high-level bacteremia. J Immunol (2008) 0.90
Milk fat globule EGF factor 8 attenuates sepsis-induced apoptosis and organ injury in alcohol-intoxicated rats. Alcohol Clin Exp Res (2010) 0.88
Computational identification of transcriptional regulators in human endotoxemia. PLoS One (2011) 0.86
Prevention of lymphocyte apoptosis in septic mice with cancer increases mortality. J Immunol (2011) 0.86
Microvesicles at the crossroads between infection and cardiovascular diseases. J Cardiovasc Pharmacol (2012) 0.86
NF-κB and enhancer-binding CREB protein scaffolded by CREB-binding protein (CBP)/p300 proteins regulate CD59 protein expression to protect cells from complement attack. J Biol Chem (2013) 0.86
Immunomodulation in sepsis: the role of endotoxin removal by polymyxin B-immobilized cartridge. Mediators Inflamm (2013) 0.86
Contractile response of norepinephrine is modulated by caspase-3 in adult rat ventricular myocytes isolated from septic rat heart. Pharmacol Res (2009) 0.84
Inhalation of activated protein C: A possible new adjunctive intervention in acute respiratory distress syndrome. Biologics (2007) 0.83
Splenocyte apoptosis and autophagy is mediated by interferon regulatory factor 1 during murine endotoxemia. Shock (2012) 0.83
Exogenous heat shock proteins (HSP70) significantly inhibit endotoxin-induced activation of human neutrophils. Dokl Biol Sci (2009) 0.83
Serum levels of caspase-cleaved cytokeratin-18 and mortality are associated in severe septic patients: pilot study. PLoS One (2014) 0.82
Role of Kir6.2 subunits of ATP-sensitive potassium channels in endotoxemia-induced cardiac dysfunction. Cardiovasc Diabetol (2013) 0.82
Different types of cell death induced by enterotoxins. Toxins (Basel) (2010) 0.82
Can we predict the effects of NF-kappaB inhibition in sepsis? Studies with parthenolide and ethyl pyruvate. Expert Opin Investig Drugs (2009) 0.82
Zoledronic acid enhances lipopolysaccharide-stimulated proinflammatory reactions through controlled expression of SOCS1 in macrophages. PLoS One (2013) 0.81
Levosimendan attenuates multiple organ injury and improves survival in peritonitis-induced septic shock: studies in a rat model. Crit Care (2014) 0.80
Targeting Fas in osteoresorptive disorders. Expert Opin Ther Targets (2010) 0.79
Inhibition of MicroRNA 195 Prevents Apoptosis and Multiple-Organ Injury in Mouse Models of Sepsis. J Infect Dis (2015) 0.79
Death to sepsis: targeting apoptosis pathways in sepsis. Crit Care (2009) 0.78
Insulin-like growth factor I promotes cord blood T cell maturation through monocytes and inhibits their apoptosis in part through interleukin-6. BMC Immunol (2008) 0.78
Apoptotic and anti-metastatic effects of the whole skin of Venenum bufonis in A549 human lung cancer cells. Int J Oncol (2011) 0.78
IL-15 Superagonist Expands mCD8+ T, NK and NKT Cells after Burn Injury but Fails to Improve Outcome during Burn Wound Infection. PLoS One (2016) 0.78
Adjuvant potential of selegiline in attenuating organ dysfunction in septic rats with peritonitis. PLoS One (2014) 0.77
Serum levels of caspase-cleaved cytokeratin-18 in patients with severe traumatic brain injury are associated with mortality: a pilot study. PLoS One (2015) 0.77
New Prognostic Biomarkers in Patients With Traumatic Brain Injury. Arch Trauma Res (2015) 0.75
Clinical application: Restoration of immune homeostasis by autophagy as a potential therapeutic target in sepsis. Exp Ther Med (2016) 0.75
Melatonin prevents chemical-induced haemopoietic cell death. Int J Mol Sci (2014) 0.75
Rho kinases (ROCKs) in sepsis-induced acute lung injury. J Thorac Dis (2012) 0.75
Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med (2001) 51.99
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med (2001) 46.58
Intensive insulin therapy in critically ill patients. N Engl J Med (2001) 40.00
Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med (2001) 27.70
Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA (2002) 16.37
Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature (2000) 13.45
Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ (2004) 9.96
Activation of the interferon system by short-interfering RNAs. Nat Cell Biol (2003) 8.63
Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med (2005) 8.55
Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther (1999) 8.28
A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med (1995) 7.88
Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix. Science (2004) 7.63
RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med (2003) 7.37
Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med (1999) 7.24
Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med (1994) 7.05
Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet (2003) 6.49
CD95's deadly mission in the immune system. Nature (2000) 5.55
Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose. Ann Intern Med (2004) 5.23
Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med (1997) 5.19
A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death. Science (2004) 4.95
Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat Med (2003) 4.04
Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol (2000) 3.58
Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties. Apoptosis (2003) 3.41
Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci U S A (1999) 3.35
Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis. J Biol Chem (2001) 3.31
Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J Mol Biol (2003) 3.27
Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J Immunol (1999) 2.92
Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med (1995) 2.59
Leukocyte apoptosis and its significance in sepsis and shock. J Leukoc Biol (2005) 2.38
Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc Natl Acad Sci U S A (2003) 2.34
Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J Immunol (1995) 2.24
Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3. Neuron (2004) 2.23
Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. JAMA (2002) 2.20
In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic mice. Blood (2005) 1.99
Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood (2004) 1.95
CD95(APO-1/Fas)-mediated apoptosis: live and let die. Adv Immunol (1999) 1.86
Non-specific effects of methyl ketone peptide inhibitors of caspases. FEBS Lett (1999) 1.83
A mechanism of cell survival: sequestration of Fas by the HGF receptor Met. Mol Cell (2002) 1.82
Virus treatment questioned after gene therapy death. Nature (1999) 1.81
Beta 2 microglobulin knockout mice are resistant to lethal intraabdominal sepsis. Am J Respir Crit Care Med (2003) 1.76
Novel therapies for sepsis: a review. J Trauma (2005) 1.74
Apoptosis in sepsis: a new target for therapeutic exploration. FASEB J (2001) 1.73
Lack of interferon response in animals to naked siRNAs. Nat Biotechnol (2004) 1.71
Cecal ligation and puncture (CLP) induces apoptosis in thymus, spleen, lung, and gut by an endotoxin and TNF-independent pathway. Shock (1997) 1.71
Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke. Circulation (2001) 1.67
Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-kappaB. Crit Care Med (2002) 1.54
Akt decreases lymphocyte apoptosis and improves survival in sepsis. J Immunol (2004) 1.54
Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis. J Clin Invest (2000) 1.49
Emerging role of Akt kinase/protein kinase B signaling in pathophysiology of diabetes and its complications. Physiol Res (2005) 1.48
How the immune system works to protect the host from infection: a personal view. Proc Natl Acad Sci U S A (2001) 1.48
The glucocorticoid receptor mediates a survival signal in human mammary epithelial cells. Cancer Res (2000) 1.45
Circulating endothelial cells in patients with septic shock. Am J Respir Crit Care Med (2001) 1.41
Inhibition of Fas/Fas ligand signaling improves septic survival: differential effects on macrophage apoptotic and functional capacity. J Leukoc Biol (2003) 1.39
Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-alpha, and FFAs to low-dose endotoxemia in humans. Am J Physiol Endocrinol Metab (2004) 1.38
Therapeutic intervention and targets for sepsis. Annu Rev Med (2005) 1.38
IL-4 and IL-2 selectively rescue Th cell subsets from glucocorticoid-induced apoptosis. J Immunol (1992) 1.37
Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab (2004) 1.31
Mechanism of hepatocellular dysfunction during hyperdynamic sepsis. Am J Physiol (1996) 1.28
Is Fas ligand or endotoxin responsible for mucosal lymphocyte apoptosis in sepsis? Arch Surg (1998) 1.26
Glucocorticoid-induced apoptosis in the thymus. Semin Immunol (1992) 1.26
Corticosteroids in sepsis: from bench to bedside? Shock (2003) 1.15
The induction of accelerated thymic programmed cell death during polymicrobial sepsis: control by corticosteroids but not tumor necrosis factor. Shock (1995) 1.14
Medicine. Targeting apoptotic pathways in cancer cells. Science (2004) 1.13
Activated protein C improves the visceral microcirculation by attenuating the leukocyte-endothelial interaction in a rat lipopolysaccharide model. Crit Care Med (2005) 1.09
Leukocyte and endothelial cell interactions in sepsis: relevance of the protein C pathway. Crit Care Med (2004) 1.09
Adrenomedullin and adrenomedullin binding protein-1 attenuate vascular endothelial cell apoptosis in sepsis. Ann Surg (2004) 1.08
Improved survival in experimental sepsis with an orally administered inhibitor of apoptosis. FASEB J (2004) 1.06
Anaphylatoxin formation in sepsis. Arch Surg (1988) 1.05
Activated protein C signals through the thrombin receptor PAR1 in endothelial cells. J Endotoxin Res (2003) 1.05
The roles of insulin and hyperglycemia in sepsis pathogenesis. J Leukoc Biol (2003) 1.04
Complement and the immune response. Curr Opin Immunol (1997) 1.04
IFN-gamma promotes Fas ligand- and perforin-mediated liver cell destruction by cytotoxic CD8 T cells. J Immunol (2004) 1.03
Inhibition of Fas signaling prevents hepatic injury and improves organ blood flow during sepsis. Surgery (2001) 1.02
Does Fas ligand or endotoxin contribute to thymic apoptosis during polymicrobial sepsis? Shock (1999) 0.97
Does hepatocellular injury in sepsis involve apoptosis? J Surg Res (1998) 0.94
Pathological aspects of apoptosis in severe sepsis and shock? Int J Biochem Cell Biol (2003) 0.93
ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis. Curr Biol (1996) 0.90
Association of endogenous G-CSF with anti-inflammatory mediators in patients with acute respiratory distress syndrome. J Interferon Cytokine Res (2003) 0.90
Increased Fas ligand expression of CD4+ T cells by HCV core induces T cell-dependent hepatic inflammation. J Leukoc Biol (2005) 0.89
Acute hyperinsulinemia restrains endotoxin-induced systemic inflammatory response: an experimental study in a porcine model. Anesthesiology (2004) 0.89
Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade. J Pept Res (2005) 0.88
Increased apoptosis in lamina propria B cells during polymicrobial sepsis is FasL but not endotoxin mediated. Am J Physiol Gastrointest Liver Physiol (2001) 0.87
Bioactive peptide design based on protein surface epitopes. A cyclic heptapeptide mimics CD4 domain 1 CC' loop and inhibits CD4 biological function. J Biol Chem (1997) 0.83
Systemic delivery of synthetic siRNAs. Methods Mol Biol (2004) 0.80
Recombinant human activated protein C in sepsis: assessing its clinical use. Am J Med Sci (2004) 0.79
Endotoxemia-induced lymphocyte apoptosis is augmented by a hyperinsulinemic-euglycemic clamp. Anesthesiology (2005) 0.77
Emerging therapies for sepsis and septic shock. Ann Acad Med Singapore (1998) 0.77
MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J Exp Med (2007) 5.48
PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc Natl Acad Sci U S A (2009) 4.23
Leukocyte apoptosis and its significance in sepsis and shock. J Leukoc Biol (2005) 2.38
Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med (2008) 2.34
In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic mice. Blood (2005) 1.99
Regulatory T cell populations in sepsis and trauma. J Leukoc Biol (2007) 1.96
The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients. Clin Chest Med (2008) 1.86
Shock-induced neutrophil mediated priming for acute lung injury in mice: divergent effects of TLR-4 and TLR-4/FasL deficiency. Am J Pathol (2002) 1.78
Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. Crit Care (2011) 1.78
The contribution of CD4+ CD25+ T-regulatory-cells to immune suppression in sepsis. Shock (2007) 1.71
Pulmonary contusion causes impairment of macrophage and lymphocyte immune functions and increases mortality associated with a subsequent septic challenge. Crit Care Med (2005) 1.65
Silencing of Fas, but not caspase-8, in lung epithelial cells ameliorates pulmonary apoptosis, inflammation, and neutrophil influx after hemorrhagic shock and sepsis. Am J Pathol (2005) 1.60
Tumor necrosis factor-alpha-stimulated polymorphonuclear leukocytes suppress migration and bactericidal activity of polymorphonuclear leukocytes in a paracrine manner. Crit Care Med (2002) 1.52
Therapeutic accessibility of caspase-mediated cell death as a key pathomechanism in indirect acute lung injury. Crit Care Med (2010) 1.49
Fas-induced pulmonary apoptosis and inflammation during indirect acute lung injury. Am J Respir Crit Care Med (2007) 1.47
Microwave ablation for hepatic malignancies: a multiinstitutional analysis. Ann Surg (2014) 1.44
Role of alveolar macrophage and migrating neutrophils in hemorrhage-induced priming for ALI subsequent to septic challenge. Am J Physiol Lung Cell Mol Physiol (2005) 1.40
Inhibition of Fas/Fas ligand signaling improves septic survival: differential effects on macrophage apoptotic and functional capacity. J Leukoc Biol (2003) 1.39
Female sex hormones regulate macrophage function after trauma-hemorrhage and prevent increased death rate from subsequent sepsis. Ann Surg (2002) 1.39
CXCR2 inhibition suppresses hemorrhage-induced priming for acute lung injury in mice. J Leukoc Biol (2004) 1.34
In vivo gene silencing (with siRNA) of pulmonary expression of MIP-2 versus KC results in divergent effects on hemorrhage-induced, neutrophil-mediated septic acute lung injury. J Leukoc Biol (2005) 1.32
Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis. Blood (2007) 1.29
Epithelial cell apoptosis and neutrophil recruitment in acute lung injury-a unifying hypothesis? What we have learned from small interfering RNAs. Mol Med (2008) 1.26
Failure to normalize lymphopenia following trauma is associated with increased mortality, independent of the leukocytosis pattern. Crit Care (2012) 1.23
BTLA expression contributes to septic morbidity and mortality by inducing innate inflammatory cell dysfunction. J Leukoc Biol (2012) 1.22
Apoptosis in sepsis: mechanisms, clinical impact and potential therapeutic targets. Curr Pharm Des (2008) 1.22
Polymicrobial sepsis induces divergent effects on splenic and peritoneal dendritic cell function in mice. Shock (2004) 1.22
Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock. Crit Care Med (2007) 1.18
Pathogenesis of indirect (secondary) acute lung injury. Expert Rev Respir Med (2011) 1.16
CD8+ T cells promote inflammation and apoptosis in the liver after sepsis: role of Fas-FasL. Am J Pathol (2007) 1.15
CD4+ lymphocytes control gut epithelial apoptosis and mediate survival in sepsis. FASEB J (2009) 1.14
Differential alterations in cardiovascular responses during the progression of polymicrobial sepsis in the mouse. Shock (2002) 1.11
Recombinant human activated protein C inhibits integrin-mediated neutrophil migration. Blood (2009) 1.11
Anti-inflammatory mechanisms of sepsis. Contrib Microbiol (2011) 1.10
Lymphocytes in the development of lung inflammation: a role for regulatory CD4+ T cells in indirect pulmonary lung injury. J Immunol (2009) 1.07
Role of activated neutrophils in chest trauma-induced septic acute lung injury. Shock (2012) 1.05
The role of hepatic invariant NKT cells in systemic/local inflammation and mortality during polymicrobial septic shock. J Immunol (2009) 1.04
Shock and hemorrhage: an overview of animal models. Shock (2005) 1.04
B and T lymphocyte attenuator expression on CD4+ T-cells associates with sepsis and subsequent infections in ICU patients. Crit Care (2013) 1.03
Deficiency of gammadelta T lymphocytes contributes to mortality and immunosuppression in sepsis. Am J Physiol Regul Integr Comp Physiol (2006) 1.01
Sepsis-induced changes in macrophage co-stimulatory molecule expression: CD86 as a regulator of anti-inflammatory IL-10 response. Surg Infect (Larchmt) (2004) 1.01
Pyogenic hepatic abscess secondary to endolumenal perforation of an ingested foreign body. J Gastrointest Surg (2011) 1.00
Programmed death 1 expression as a marker for immune and physiological dysfunction in the critically ill surgical patient. Shock (2012) 0.99
Mechanisms of indirect acute lung injury: a novel role for the coinhibitory receptor, programmed death-1. Ann Surg (2012) 0.97
Plasmacytoid dendritic cells control lung inflammation and monocyte recruitment in indirect acute lung injury in mice. Am J Pathol (2009) 0.97
The dual functions of receptor interacting protein 1 in fas-induced hepatocyte death during sepsis. Shock (2011) 0.97
Genetic disruption of protein kinase Cδ reduces endotoxin-induced lung injury. Am J Physiol Lung Cell Mol Physiol (2012) 0.95
Divergent roles of murine neutrophil chemokines in hemorrhage induced priming for acute lung injury. Cytokine (2005) 0.94
Pathological aspects of apoptosis in severe sepsis and shock? Int J Biochem Cell Biol (2003) 0.93
Inhibition of CD1d activation suppresses septic mortality: a role for NK-T cells in septic immune dysfunction. J Surg Res (2003) 0.93
Contribution of anti-inflammatory/immune suppressive processes to the pathology of sepsis. Front Biosci (2006) 0.93
Sex-specific p38 MAP kinase activation following trauma-hemorrhage: involvement of testosterone and estradiol. Am J Physiol Endocrinol Metab (2003) 0.91
Deficiency of Bid protein reduces sepsis-induced apoptosis and inflammation, while improving septic survival. Shock (2010) 0.90
Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T. Cancer Immunol Immunother (2015) 0.90
SOCS-1 is a central mediator of steroid-increased thymocyte apoptosis and decreased survival following sepsis. Apoptosis (2007) 0.89
Survival analysis of patients with stage I and II hepatocellular carcinoma after a liver transplantation or liver resection. HPB (Oxford) (2014) 0.89
Activation of common antiviral pathways can potentiate inflammatory responses to septic shock. Shock (2006) 0.88
Apoptosis. Crit Care Med (2005) 0.88
Kupffer cells protect liver sinusoidal endothelial cells from Fas-dependent apoptosis in sepsis by down-regulating gp130. Am J Pathol (2013) 0.88
Regionalization and outcomes of hepato-pancreato-biliary cancer surgery in USA. J Gastrointest Surg (2014) 0.87
Microwave ablation using 915-MHz and 2.45-GHz systems: what are the differences? HPB (Oxford) (2013) 0.87
Beneficial versus detrimental effects of neutrophils are determined by the nature of the insult. J Am Coll Surg (2007) 0.86
Fate and effects of adult bone marrow cells in lungs of normoxic and hyperoxic newborn mice. Am J Respir Cell Mol Biol (2008) 0.86
Blockade of apoptosis as a rational therapeutic strategy for the treatment of sepsis. Novartis Found Symp (2007) 0.86
Identification of B7-H1 as a novel mediator of the innate immune/proinflammatory response as well as a possible myeloid cell prognostic biomarker in sepsis. J Immunol (2013) 0.86
Paracrine suppression of apoptosis by cytokine-stimulated neutrophils involves divergent regulation of NF-kappaB, Bcl-X(L), and Bak. Shock (2002) 0.86